Posted opportunity — confirm at source
DoW Breast Cancer, Clinical Research Extension Award
Defense Health Agency Contracting Activity - DHACA · HT942526BCRPCREA2
See source for award amount
2026-11-18-00-00-00
Confirm exact timezone in the announcement.Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Geographic eligibility and all attachment-specific conditions require review of the original announcement.
Matching funds & resources
Source matching-funds field: Not Required.
Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.
About this opportunity
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Distinctive Features: • The research team must include two or more breast cancer consumer advocates. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.
Funding geography: Not specified — review source. A funder’s address does not establish eligibility.
Review original source ↗Funding instrument: Grant. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.
Source fields and evidence
id: 363671
Source ↗ · id
opportunityNumber: HT942526BCRPCREA2
Source ↗ · opportunityNumber
opportunityTitle: DoW Breast Cancer, Clinical Research Extension Award
Source ↗ · opportunityTitle
revision: 3
Source ↗ · revision
agencyDetails: {"code":"AMRAA","seed":"DOD-AMRAA","agencyName":"Defense Health Agency Contracting Activity - DHACA","agencyCode":"DOD-AMRAA","topAgencyCode":"DOD"}
Source ↗ · agencyDetails
owningAgencyCode: DOD-AMRAA
Source ↗ · owningAgencyCode
cfdas: [{"id":435161,"opportunityId":363671,"cfdaNumber":"12.420","programTitle":"Military Medical Research and Development"}]
Source ↗ · cfdas
applicantTypes: [{"id":"99","description":"Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled \"Additional Information on Eligibility\""}]
Source ↗ · applicantTypes
fundingInstruments: [{"id":"G","description":"Grant"}]
Source ↗ · fundingInstruments
fundingActivityCategories: [{"id":"ST","description":"Science and Technology and other Research and Development"}]
Source ↗ · fundingActivityCategories
awardFloor: none
Source ↗ · awardFloor
awardCeiling: none
Source ↗ · awardCeiling
responseDate: Nov 18, 2026 12:00:00 AM EST
Source ↗ · responseDate
responseDateStr: 2026-11-18-00-00-00
Source ↗ · responseDateStr
costSharing: false
Source ↗ · costSharing
lastUpdatedDate: Sep 03, 2026 08:55:51 AM EDT
Source ↗ · lastUpdatedDate
status: posted
Source ↗ · oppHits[id=363671].oppStatus
Related collections: Research funding opportunities · Defense health research funding ·
Build your funding pipeline.
Save opportunities, filter by fit, and export your deadlines with membership.
View plans from $49/month ↗